🤝 Last week, we announced an expanded partnership with @MolecularPrtnrs, adding the development of six new targeted alpha therapeutic candidates to our pipeline - bringing the total to ten programs between the two companies.
Read the Press Release: oranomed.com/en/resources/n…
Read the Press Release: oranomed.com/en/resources/n…